Cardiovascular Conditions


Program Details

  • Intended Audience:  Pharmacists interested in cardiovascular conditions
  • Universal Activity Number: 0012-0000-23-030-H01-P
  • Contact Hours: 6.0 Consultant Recertification/General hours of ACPE continuing education for pharmacists
  • Program Fees: 
    • Regular Registration: $110.00
    • UF Preceptor/Career Coach: $90.00
    • UF COP Faculty: $80.00
  • UAN Release Date: 10/01/2023
  • UAN Expiration Date: 10/01/2026
  • Activity Type: Knowledge
  • Program Support: No outside financial support was provided.
  • Format Type: This course is self-paced, fully online.
  • Time to Complete: All coursework must be completed within 24 weeks from the date of registration or before date of UAN expiration, 10/01/2026, whichever comes first. This course will no longer be eligible for CE credit after 10/01/2026.

Summary

This CPE program will review the treatment and management of various cardiology health conditions that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed.

This course is approved by the Florida Board of Pharmacy for 6.0 contact hours to meet requirements pursuant to CHAPTER 64B16-26, Florida Statutes, and Rule 64B16-26.300, Florida Administrative Code.


Objectives

At the completion of this activity, the participant will be able to:

  • Interpret clinical and laboratory tests related to disease and medication management for common cardiology disease states seen in the ambulatory care setting.
  • Use clinical practice guidelines to establish goals of therapy, gaps in care, and appropriateness of pharmacological and nonpharmacological interventions for common cardiology disease states seen in the ambulatory care setting.
  • Assess patient-specific information to create an individualized care plan including appropriateness, efficacy, and safety for drug therapy and lifestyle modifications for common cardiology disease states seen in the ambulatory care setting.
  • Develop appropriate follow-up and monitoring strategies to evaluate patient response to drug therapy for common cardiology disease states seen in the ambulatory care setting.

Program Overview

Lecture 1.1: Anticoagulation

  • Interpret clinical and laboratory tests related to disease and medication management.
  • Use clinical practice guidelines to establish goals of therapy, gaps in care, and appropriateness of pharmacological and nonpharmacological interventions.
  • Assess patient-specific information to create an individualized care plan including appropriateness, efficacy, and safety for drug therapy and lifestyle modifications.
  • Develop appropriate follow-up and monitoring strategies to evaluate patient response to drug therapy.

Lecture 1.2: Heart Failure

  • Interpret clinical and laboratory tests related to disease and medication management.
  • Use clinical practice guidelines to establish goals of therapy, gaps in care, and appropriateness of pharmacological and nonpharmacological interventions.
  • Assess patient-specific information to create an individualized care plan including appropriateness, efficacy, and safety for drug therapy and lifestyle modifications.
  • Develop appropriate follow-up and monitoring strategies to evaluate patient response to drug therapy.

Lecture 1.3: Hyperlipidemia

  • Perform patient assessments.
  • Evaluate and manage diseases and health conditions, including appropriate drug therapy changes, in collaboration with other health care practitioner.
  • Order, perform, and interpret clinical and laboratory tests related to collaborative pharmacy practice.

Lecture 1.4: Hypertension

  • Review updated definitions and goals from the 2017 AHA/ACC hypertension guidelines.
  • Perform patient assessment for a patient with hypertension.
  • Order, perform, and interpret clinical and laboratory testing for a patient with hypertension.
  • Evaluate and manage hypertension, including drug therapy changes in collaboration with other health care providers.

Lecture 1.5: Secondary Prevention of Acute Coronary Syndrome

  • Interpret clinical and laboratory tests related to disease and medication management.
  • Use clinical practice guidelines to establish goals of therapy, gaps in care, and appropriateness of pharmacological and nonpharmacological interventions.
  • Assess patient-specific information to create an individualized care plan including appropriateness, efficacy, and safety for drug therapy and lifestyle modifications.
  • Develop appropriate follow-up and monitoring strategies to evaluate patient response to drug therapy.

Requirements for Successful Course Completion

In order to earn credit for this course, participants must pass a final assessment with a score of 70% or higher. Two chances to pass the assessment will be given. If a passing score is not earned by the second attempt, the participant must re-enroll in the course. Upon successful completion of all coursework, participants must complete a course evaluation form.


Course Access

To access your course after enrollment, please click the link below.

http://elearning.ufl.edu/

Click the blue “Log in to Continuing Education” button and enter your login credentials. You should then see your course on the Canvas dashboard or by clicking Courses>All Courses.


Disclosure Statement

Eric A Dietrich, Pharm.D., BCACP, CPC-A, CEMC, CPB (speaker) has disclosed that he receives an unrestricted Investigator-initiated Research Grant from BMS/Pfizer. All of the relevant financial relationships listed for Dr. Dietrich have been mitigated. No other speaker, reviewer, or planning committee member in a position to control content has any financial relationships to disclose.

James Taylor
Department: Pharmacotherapy & Translational Research

James Taylor Pharm.D., CDE, BCACP

Professor
Julio D Duarte
Department: Pharmacotherapy & Translational Research

Julio D Duarte Pharm.D., Ph.D., FAHA

Associate Professor
Eric A Dietrich
Department: Pharmacotherapy & Translational Research

Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB

Associate Professor
Teresa E Roane
Department: Pharmacotherapy & Translational Research

Teresa E Roane PharmD, MBA, BCACP

Director Continuing Pharmacy Education; Clinical Associate Professor
Rachel Shaddock
Department: Pharmacotherapy & Translational Research

Rachel Shaddock

Resident

Additional Resources

Please review the resources below before registering for the course.


ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.